About Technology Issues FAQ

Links

Osimertinib in T790M-positive and -negative patients with EGFR-mutated advanced non-small cell lung cancer (the TREM-study)

Osimertinib in T790M-positive and -negative patients with EGFR-mutated advanced non-small cell lung cancer (the TREM-study) — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.